Semaglutide

(Compounded injectable)

Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone involved in appetite and blood sugar regulation. It works by slowing gastric emptying, increasing fullness, and reducing hunger, which can support improved insulin sensitivity and weight loss.

When combined with nutrition, exercise, and lifestyle changes, clinical studies show an average weight loss of 15–17% over time.

Results vary.

There are No guarantees, lifestyle changes are necessary for any weight loss program. Consents are required.

Tirzepatide

( Compounded injectable)

Tirzepatide is a dual-action medication that targets both GLP-1 and GIP receptors, two natural hormones involved in appetite, metabolism, and insulin regulation. This combined action can enhance satiety, reduce appetite, and improve metabolic efficiency.

When used alongside lifestyle changes, such as nutrition and exercise: studies show an average weight loss of 20–22% in appropriate patients. Some individuals experience fewer gastrointestinal side effects compared to GLP-1–only therapies.

Results vary.

There is no guarantee, lifestyle changes are necessary for any weight loss program. Consents are required.

Oral Options:

Phentermine

or

Bupropion/Naltrexone ( Contrave)

Phentermine and or bupropion/naltrexone are FDA-approved oral medications that can help with appetite suppression and weight management. On average, patients may lose about 5–7% of their body weight with these treatments.

SOMETIMES: Prescribed with a GLP-1 medication such as semaglutide or tirzepatide, they can provide an added boost, working together to improve appetite control, reduce cravings, and support long-term weight loss success.

I do not prescribe phentermine long-term.

There is no guarantee, lifestyle changes are necessary for any weight loss program. Consents are required.

Used alone short term only: ( no GLP1 prescribed) $110 / month